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Abstract
Background: The mammary gland is responsible for the transfer of a tremendous amount of zinc (,1–3 mg zinc/day) from
maternal circulation into milk during lactation to support the growth and development of the offspring. When this process
is compromised, severe zinc deficiency compromises neuronal development and immune function and increases infant
morbidity and/or mortality. It remains unclear as to how the lactating mammary gland dynamically integrates zinc import
from maternal circulation with the enormous amount of zinc that is secreted into milk.
Methodology/Principal Findings: Herein we utilized X-ray fluorescence microscopy (XFM) which allowed for the
visualization and quantification of the process of zinc transfer through the mammary gland of the lactating mouse. Our data
illustrate that a large amount of zinc first accumulates in the mammary gland during lactation. Interestingly, this zinc is not
cytosolic, but accumulated in large, discrete sub-cellular compartments. These zinc pools were then redistributed to small
intracellular vesicles destined for secretion in a prolactin-responsive manner. Confocal microscopy identified mitochondria
and the Golgi apparatus as the sub-cellular compartments which accumulate zinc; however, zinc pools in the Golgi
apparatus, but not mitochondria are redistributed to vesicles destined for secretion during lactation.
Conclusions/Significance: Our data directly implicate the Golgi apparatus in providing a large, mobilizable zinc storage
pool to assist in providing for the tremendous amount of zinc that is secreted into milk. Interestingly, our study also
provides compelling evidence that mitochondrial zinc pools expand in the mammary gland during lactation which we
speculate may play a role in regulating mammary gland function.
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Introduction
The development of the mammary gland and lactation is the
hallmark of the evolution of mammalian species. During lactation,
the mammary gland must tightly regulate the accumulation,
production and the ultimate secretion of a complex mixture of
nutrients and non-nutritive factors into milk to nourish the
developing offspring. This complex process is primarily regulated
through lactogenic hormone activation [1,2,3,4] of highly
specialized, secretory mammary epithelial cells. Mammary
epithelial cells surround the lumen of mammary gland alveoli
into which milk components are secreted, pooled and eventually
released in a hormonally-mediated manner. Regulation of milk
component secretion is dependent upon the specific milk
constituent. For example, lactose [5] and secreted proteins [6]
are synthesized in the Golgi apparatus and transported through
the secretory compartment for exocytosis into milk while lipids are
extruded from the apical membrane in the form of droplets
encased within the milk fat globule membrane [7]. Hormones and
growth factors are transcytosed directly across the mammary
epithelial cell [6]. Small ions and water [8] may be directly
transported across the apical membrane into the alveolar lumen
by specific transporters. The mechanisms through which different
trace elements such as iron, copper and zinc (Zn) are exported into
milk are unique, reflecting the specificity of trace element transport
systems [9,10,11,12]. Additionally, the biological complexation of
each trace element in milk is different. For example, iron is bound
to lactoferrin and/or transferrin in a species-dependent manner
[13,14] while copper is generally bound to ceruloplasmin and
metallothionein [15,16]. In stark contrast, Zn is predominantly
found loosely associated with small molecular weight ligands such
as citrate [15,17]. Moreover, milk Zn concentration is ,10 times
greater (,2 mg/L,) than the concentration of iron or copper in
milk (,0.2 mg/L). This suggests that the mammary gland has
developed unique mechanisms to transfer such an extraordinary
amount of Zn into milk during lactation.
How the mammary gland facilitates and regulates the transfer of
such a large amount of Zn for secretion into milk during lactation
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transfer into milk involves the integration of mammary gland Zn
import, Zn sequestration and Zn secretion mechanisms [18,19] in
a hormonally regulated manner. Presumably, Zn acquisition from
maternal circulation by the mammary gland must first be
increased to provide enough Zn for secretion into milk. In fact,
the lactogenic hormone prolactin increases Zn uptake in
mammary cells [18], suggesting that hormonal regulation of Zn
uptake into the mammary cell is one point of control. Current
dogma suggests that Zn import from maternal circulation likely
occurs through members of the Zip family (SLC39A)o fZ n
importers. A specific Zip protein(s) responsible for regulating Zn
import into the mammary gland from maternal circulation has yet
to be elucidated. Following Zn uptake, the mammary epithelial
cell must secrete a tremendous amount of loosely bound Zn into
milk. Studies suggest that similar to pancreas [20], brain [21], and
prostate [22] the mammary gland may utilize a vesicular process
to accomplish such bulk and efficient Zn secretion [23]. We
postulate that the mammary epithelial cell must first accumulate
Zn into intracellular pools and then redistribute these Zn pools to
facilitate such a massive amount of Zn secretion in a hormonally-
mediated manner. Consistent with this hypothesis, our recent
evidence indicates that vesicles containing ‘‘labile’’ Zn (zinco-
somes) accumulate in cultured mammary epithelial cells prior to
secretion from the cell [23]. Additionally, there is evidence that
mitochondria may participate in Zn sequestration and redistribu-
tion in several highly specialized cell-types. For example,
mitochondrial Zn pools in neurons accumulate and are later
mobilized in response to exogenous or endogenous cues [24] prior
to transfer to specific cytosolic Zn pools [25]. Comparisons are
often made between the secreting mammary and prostate glands.
Interestingly, Zn levels in mitochondria isolated from lateral
prostate are higher (,20-fold) compared with mitochondria from
other soft tissues [26]. High mitochondria Zn levels parallel Zn
levels secreted into the alveoli of the lateral prostate [22]
suggesting that the source of Zn for secretion into prostate fluid
may be Zn previously sequestered in these mitochondrial pools. As
a result, mitochondria may provide a ‘‘labile’’ Zn pool in some
specialized cell types with unique Zn secretory requirements such
as the prostate and mammary glands.
To explore the hypothesis that the lactating mammary gland
must first accumulate Zn prior to secretion, we used the mouse
mammary gland and cultured normal mouse mammary epithelial
cells as models. We first utilized X-ray fluorescence microscopy
(XFM) to visualize and quantify the expansion of Zn pools in the
lactating mammary gland and explored the redistribution of these
Zn pools in response to the lactogenic hormone prolactin in vivo.
Secondly, we utilized cultured mammary epithelial cells to identify
the specific sub-cellular compartments that accumulate Zn which
is then redistributed for secretion from the cell. In this report we
document that Zn accumulates in two discrete intracellular pools
which include the Golgi apparatus and mitochondria. However,
unlike observations in neurons and prostate, only Zn pools within
the Golgi apparatus appear to be ‘‘labile’’ and thus redistributed to
exocytotic vesicles for secretion.
Results
As a model system to test the hypothesis that the mammary
gland must first accumulate Zn prior to secretion into milk we
compared the concentration and spatial distribution of Zn using
XFM. As illustrated in Figure 1, histological features of the
mammary gland change dramatically during the transition from a
non-lactating to a lactating tissue. Figure 1 illustrates the compact,
undifferentiated nature of the non-lactating mammary gland. In
contrast, the mammary gland becomes highly differentiated
during lactation. There is extensive morphological reorganization
into discrete alveoli, surrounded by secretory mammary epithelial
cells. These cells surround an open lumen into which milk
components are secreted and pooled until removed in response to
suckling. Moreover, the mammary gland accumulates a large
amount of Zn during lactation to help ensure adequate transfer
into milk. To explore the distribution of sub-cellular Zn pools in
mammary epithelial cells, we examined the spatial distribution of
intracellular Zn pools in lactating mammary gland in vivo and in
cultured mammary epithelial cells in vitro (Figure 2). XFM analysis
of mouse mammary gland samples demonstrated elemental
distributions for sulfur (correlated to overall cell thickness) and
phosphorus (utilized as a marker for nuclei) to be typical of
eukaryotic cells [27]. We examined the spatial distribution of Zn
relative to phosphorus in mammary cells from lactating mice that
had been recently suckled (Figure 2, Suckled). Visualization of the
spatial distribution Zn pools in suckled mice represented a ‘‘basal’’
starting point to explore the initial accumulation and subsequent
redistribution of intracellular Zn pools. We consistently detected
Zn associated either directly with nuclei and/or in a distinct peri-
nuclear compartment in recently suckled mice.
We next explored the spatial distribution of intracellular Zn
pools in the mammary gland following Zn acquisition from
maternal circulation during lactation. As can be seen in Figure 2
(Post-suckled), the lactating mammary epithelial cell accumulated
significant Zn in preparation for its subsequent secretion into milk.
Approximately 50% of the intracellular Zn was associated with a
large, distinct nuclear/peri-nuclear pool, while the remaining Zn
appeared to be concentrated in a few, large intracellular pools.
These data suggest that Zn accumulates in large intracellular pools
both in close approximation to and distal from the nucleus. This
intracellular accumulation of Zn in mammary epithelial cells
appears to occur in response to prolactin as mice injected with
bromocriptine (which eliminated circulating prolactin) accumulat-
ed significantly less Zn compared with vehicle-treated mice. The
minimal amount of Zn that was detected within the mammary
epithelial cell remained distinctly associated with the nuclear/peri-
nuclear compartment.
We have previously determined that prolactin stimulates Zn
secretion from cultured mammary cells in vitro [23]. This suggests
that the intracellular Zn storage pools we observed in the lactating
mammary gland are redistributed for secretion in response to
lactogenic cues. To explore effects of prolactin on cellular Zn
redistribution in vivo, we injected mice with haloperidol which
stimulated prolactin secretion ,5-fold (6756427 ng/mL com-
pared with 1566120 ng/mL in vehicle-treated mice). As indicated
in Figure 2, haloperidol treatment clearly resulted in the spatial
redistribution of intracellular Zn pools from the large, distinct
intracellular Zn pools observed in post-suckled mice to numerous
smaller vesicles which were distributed throughout the mammary
epithelial cell. This did not appear to reflect increased Zn
accumulation as the amount of Zn within the mammary epithelial
cell from haloperidol-treated mice was actually lower that the
amount of Zn in post-suckled, vehicle-treated controls. These
observations are consistent with our previous determination that
prolactin increases Zn secretion from mammary cells through a
vesicular process [23].
Characterization of these intracellular Zn pools is critical to
understanding how this process is regulated. The current
limitations in XFM technology with respect to sub-cellular
resolution required that we utilize cultured mammary epithelial
cells to investigate these intracellular Zn pools more directly.
Zn Pools in Mammary Gland
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accumulated and sequestered in peri-nuclear as well as large,
discrete intracellular pools. To explore the identity of these
intracellular Zn pools, we hypothesized that mitochondria, ER,
Golgi and/or lysosomes may provide sites for Zn accumulation.
To test this hypothesis, we first visualized Zn pools using confocal
microscopy. We capitalized on the specificity of RhodZin-3 and
FluoZin-3, Zn-specific fluorophores which are specific for
mitochondrial and ‘‘labile’’ Zn pools in vesicles to explore this
hypothesis. Confocal micrographs of mammary epithelial cells in
vitro clearly detected discrete Zn pools localized in peri-nuclear
compartments including mitochondria and vesicles (Figure 3A).
Consistent with our results in vivo, quantitative fluorometry in
cultured mammary epithelial cells indicated that prolactin
stimulates significant Zn accumulation into pools which appears
to reflect increases in both mitochondria (,10-fold increase) and
vesicle (,4-fold increase) Zn pools (Figure 3B). We interpreted this
data to indicate that both mitochondria and vesicles are storage
depots for Zn accumulation in mammary epithelial cells which
may be redistributed to provide Zn for secretion.
To ascertain the identity of the vesicular pool(s), the spatial
distribution of intracellular Zn pools in mammary cells was
visualized by confocal microscopy. We verified that chloroquine
pre-treatment disrupted the lysosomes as illustrated by Lysotracker
Green staining (Figure 4A and 4B); however, the spatial
distribution of FluoZin-3 fluorescence was not disrupted by
chloroquine pre-treatment (Figure 4C and 4D). Identical results
were obtained in cells differentiated to a secreting phenotype (data
not shown), thus eliminating the lysosomes as a Zn-rich
compartment in mammary epithelial cells. We next attempted to
co-localize intracellular Zn pools with the endoplasmic reticulum
(ER) using ER Tracker. As illustrated in Figure 5, no co-
localization between the ER and FluoZin-3 was detected
eliminating the ER as a Zn-rich compartment in mammary cells.
Identical results were obtained in cells differentiated to a secreting
phenotype (data not shown). In fact, intracellular Zn pools were
associated with a distinct compartment immediately proximal to
the ER (Figure 5, inset). In contrast, we co-localized FluoZin-3
with Bodipy TR which stains sphingolipids and is routinely used to
visualize the Golgi apparatus (Figure 6). This suggested that the
Golgi apparatus was a site of Zn accumulation in mammary
epithelial cells. To verify the association of ‘‘labile’’ Zn pools with
the Golgi apparatus, pre-treatment with Brefeldin A effectively
disrupted the Golgi apparatus and clearly affected the spatial
Figure 1. XFM analysis of the mammary gland from non-lactating and lactating mice. Mouse mammary gland (20 mm) was visualized by
phase contrast microscopy (206magnification) and analyzed using XFM. The alveoli lumen (L) is surrounded by a single layer of mammary epithelial
cells (MEC). The corresponding element (phosphorus, P; zinc, Zn) and its minimum and maximum threshold values in micrograms per square
centimeter are given above each image. The rainbow-colored scale bar reflects the signal intensity measured as micrograms per square centimeter in
each pixel, with darker pixels representing areas of low concentration and brighter pixels representing areas of increasing concentration. A scale bar
(20 mm) is shown below the elemental maps.
doi:10.1371/journal.pone.0011078.g001
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that the Golgi apparatus contains a Zn-rich intracellular pool.
Interestingly, cells differentiated to a secreting phenotype with
prolactin had Zn pools that were partially associated with the
Golgi apparatus and partially another distinct non-ER and non-
lysosome but vesicular compartment. These results are consistent
with our observations using XFM in vivo and our previous
determination that Zn accumulates into ZnT2-associated exocy-
totic vesicles for secretion from the mammary cell in response to
prolactin [23].
To quantify this redistribution in vitro, we differentiated cells to a
secreting phenotype thereby permitting the accumulation of
intracellular Zn pools (i.e., into mitochondria and the Golgi
apparatus). We then treated secreting cells with prolactin to
determine if we could mobilize these Zn pools assessed by changes
in RhodZin-3 and FluoZin-3 fluorescence. We did not detect a
reduction in mitochondrial Zn pools using RhodZin-3 (data not
shown). In contrast, we detected a significant decline (p,0.001) in
vesicular Zn pools using FluoZin-3 in response to prolactin
stimulation (Figure 8) consistent with our observations in vivo.
Together our data suggest that Zn accumulates in mitochondria
and the Golgi apparatus in a hormonally-dependent manner, after
which Golgi apparatus Zn pools are redistributed in response to
prolactin for secretion. In contrast, while mitochondrial Zn pools
do expand, these pools do not appear to contribute significantly to
Zn secretion. Importantly, our data demonstrate this redistribution
occurs both in vitro and in vivo.
Discussion
The secretion of an extraordinary amount of Zn into milk
during lactation is critical to providing optimal nutrition for
maximizing the health and development of the nursing offspring.
The process by which the mammary gland takes up such an
astonishing amount of Zn from maternal circulation, and then
ultimately secretes it into milk must integrate Zn import,
accumulation and secretion mechanisms [28,29,30]. Moreover,
consistent with the regulation of lactation and the production and/
or secretion of other milk components, the coordination of Zn
secretion processes must be regulated through complex hormone-
mediated events. X-ray fluorescence microscopy is a powerful tool
permitting the visualization and quantification of metal pools in
tissue sections [27]. The use of XFM in this study allowed us to
directly visualize the accumulation and redistribution of discrete
intracellular Zn pools in the lactating mammary gland. Our data
illustrated that Zn imported from maternal circulation is not likely
transported directly across the mammary gland and into milk but
is instead accumulated in intracellular compartments within the
Figure 2. XFM analysis of intracellular Zn pools in mouse mammary gland during lactation. Mouse mammary gland (20 mm) was
analyzed using XFM. The corresponding element (phosphorus, P; zinc, Zn) and its minimum and maximum threshold values in micrograms per square
centimeter are given above each image. The rainbow-colored scale bar reflects the signal intensity measured as micrograms per square centimeter in
each pixel, with darker pixels representing areas of low concentration and brighter pixels representing areas of increasing concentration. A scale bar
(10 mm) is shown below the elemental maps. Zinc and phosphorus maps of ,1–4 mammary cells in the mammary gland from a mouse that had
suckled her offspring for 30 min (suckled; used as a baseline), a suckled mouse, 60 min post-suckling (Post-suckled; reflecting Zn accumulation), a
mouse injected with bromocriptine (Bromocriptine; used to eliminate prolactin secretion) and a mouse injected with haloperidol (Haloperidol; used
to increase prolactin secretion). The red circles on the Zn maps denote corresponding nuclei.
doi:10.1371/journal.pone.0011078.g002
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paradigm likely permits tight control of the process of bulk Zn
secretion. While we cannot yet identify these discrete intracellular
compartments by hard XFM due to limited spatial resolution, our
data from cultured mammary cells suggest that several distinct
cellular compartments may play a role in this process. A key
finding from this study was the determination that Zn accumulates
in large discrete pools associated with and/or proximal to the
nucleus in mammary cells of lactating mice. Our data in vivo and in
vitro clearly implicate mitochondria and the Golgi apparatus as
sites of Zn accumulation in this cell type.
Mitochondria have a specific requirement for Zn and have been
shown to accumulate Zn in neurons and prostate. As a result, it
has been postulated that mitochondria serve as a mobilizable pool
of Zn which is dependent upon cellular requirements [31]. In
neurons, mitochondrial Zn accumulation is believed to occur
through Ca transport mechanisms and is redistributed to a
cytosolic pool in response to Ca-mediated signaling mechanisms
[24]. Consistent with our previous study and observations in
prostate mitochondria [32,33,34] and spermatogonia mitochon-
dria [35], results from this study directly confirmed that
mitochondria in cultured mammary epithelial cells accumulate
Zn. Understanding how mitochondria accumulate Zn is of
particular interest. The Zn transporter Zip8 is associated with
mitochondria in lung epithelium [36]. Although directionality of
Zn transport via Zip8 has not been substantiated, topology
prediction suggests that it would transport Zn away from
mitochondria and into the cytoplasm. In contrast, we have
recently determined that one mechanism through which mito-
chondria in mammary epithelial cells directly accumulate Zn is
through the Zn transporter ZnT2 (SLK, unpublished observa-
tions). Importantly, expression of ZnT2 is increased in response to
the lactogenic hormone prolactin [19,23], consistent with effects of
prolactin on mitochondrial Zn accumulation. A key question that
arises from this observation is, do mitochondrial Zn pools provide
a mobilizable pool of Zn for secretion? In contrast to neurons, our
Figure 3. The lactogenic hormone prolactin increases vesicular and mitochondrial Zn pools in mammary cells. (A) Representative
confocal images to illustrate vesicular and mitochondrial Zn pools detected using FluoZin-3 (green) and RhodZin-3 (red), respectively, in mammary
cells (HC11). Scale bar (5 mm). (B) Mammary cells were treated with prolactin (1 mM) for 24 h and the accumulation of Zn in vesicular and
mitochondrial Zn pools were detected by fluorometry using FluoZin-3 (green) and RhodZin-3 (red), respectively. Data represent mean fluorescence 6
standard deviation, n=6 samples/treatment. Asterisk indicates a significant effect of treatment (p,0.001).
doi:10.1371/journal.pone.0011078.g003
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support the postulate that mitochondria serve as a rapid
hormonally-regulated mobilizable Zn pool in mammary cells.
Instead, we speculate that changes in mitochondrial Zn pools may
perform regulatory functions to modulate the phenotype of the
highly differentiated secretory epithelium during lactation. Studies
are currently underway to test this hypothesis.
In addition to mitochondria, the endoplasmic reticulum and
Golgi apparatus reside in close approximation to the nucleus
suggesting that these compartments may sequester Zn prior to
secretion into milk. In fact, a recent study using XFM detected a
peri-nuclear Zn pool in keratinocytes which was postulated to
reside in the ER or Golgi apparatus [37]. Our studies provide
direct evidence that the Golgi apparatus but not the ER provides a
Zn-rich pool in mammary epithelial cells. Several Zn transporters
have been postulated to transport Zn into the Golgi apparatus
including ZnT4-ZnT7 [38,39,40]. Our documentation of a Zn-
rich and mobilizable pool in the Golgi apparatus of mammary
cells is consistent with observations of reduced Zn content in milk
of ZnT4
2/2 (lethal milk) mice [41] and suggest that ZnT4
2/2 mice
cannot expand the Zn pool in the Golgi apparatus to provide Zn
for secretion into milk. However, Michalcyzk et al. noted that
there was no obvious overlap between ZnT4 and Zinquin-stained
vesicles in PMC42 cells [39] implicating ZnT4 in the accumula-
tion of ‘‘non-labile’’ Zn pools as well. ZnT4 may not be uniquely
responsible for this process. In addition to ZnT7 [40,42], the yeast
homologues to ZnT5 (Msc2p) [43] and ZnT6 (Zrg17) [44,45] have
all been localized to the ER and/or the Golgi apparatus and
studies support a role for ER and/or Golgi apparatus Zn
accumulation. Bioinformatic prediction suggests that ZnT5 and
ZnT7 but not ZnT6 are expressed in the mammary gland [46]
suggesting that ZnT5 and ZnT7 may also play a role in Zn
sequestration in the ER and/or Golgi apparatus of the mammary
epithelial cell as well. However, to our knowledge ZnT5-null [47]
and ZnT7-null [48] mice do not have defects in Zn secretion from
the mammary gland, suggesting that unlike ZnT4, ZnT5 and
Figure 4. Labile Zn pools are not associated with lysosomes. Representative confocal micrographs of lysosomes detected with Lysotracker
Green in untreated cells (Lysotracker) and cells treated with chloroquine diphosphate (Lysotracker +CLQ).. Images verify that chloroquine
diphosphate disrupts lysosomes in HC11 cells. Representative confocal micrographs of ‘‘labile’’ Zn pools detected using FluoZin-3 in untreated cells
(FluoZin-3) and cells treated with chloroquine diphosphate (FluoZin-3 +CLQ). Images illustrate that the distribution of ‘‘labile’’ Zn pools in mammary
cells is not affected by lysosomal disruption.
doi:10.1371/journal.pone.0011078.g004
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bioinformatic prediction must always be viewed with caution and
followed up with empirical analysis; thus ZnT6 cannot be ruled
out as a contributor to mammary gland Zn metabolism.
An interesting observation we made in this study is that once
accumulated in the Golgi apparatus, intracellular Zn pools are
then redistributed into smaller vesicles dispersed throughout the
cell in response to subsequent prolactin stimulation in vivo. This is
consistent with our previous data in vitro which indicate that the
lactogenic hormone prolactin increases Zn uptake, Zn accumu-
lation and Zn secretion in mammary cells [11,18,23]. Clearly the
secretion of vesicularized Zn pools would provide a successful
mechanism to export the large amount of Zn into milk that is
required by the developing neonate. Furthermore, our visualiza-
tion of vesicular Zn accumulation is consistent with the theory of
zincosomes [49] which function as a reversible Zn storage
compartment. A recent study using XFM determined that this
vesicular Zn is found in complex with sulfur, histidine and oxygen
and thus is technically not ‘‘free’’ [49]. Importantly, this binding
allows for accumulation against a concentration gradient but is
predicted to have a lower affinity for Zn than binding motif found
in structural sites like Zn fingers (Cys2His2, Cys3His, Cys4), or in
metallothionein (Cys4) [49]. Similarly, studies indicate that Zn in
milk is found in loose complex with the small molecular weight
ligand citrate [50]. Our detection of mobilizable Zn-rich pools in
the Golgi apparatus is consistent with the concept that a Zn/
citrate complex may be accumulated in the Golgi apparatus prior
to secretion into milk through the exocytosis of Golgi apparatus-
derived vesicles [5]. Alternatively, Zn may accumulate in a Golgi
apparatus storage pool which is directly exported from the Golgi
apparatus and subsequently taken up into secretory vesicles. In
support of this latter postulate, two members of the Zip family of
Zn transporters, Zip7 [51] and Zip9 [52] are associated with the
Golgi apparatus, implicating them in Zn export from this
organelle. This postulate supports our previous characterization
of a role for ZnT2 in the accumulation of Zn into VAMP8-
containing exocytotic vesicles prior to secretion from the cell [23].
Clearly, further studies are needed to determine if Zip7 and/or
Zip9 facilitate Zn mobilization from the Golgi apparatus for
import into ZnT2-associated secretory vesicles and if so, what the
regulatory contribution of the Golgi apparatus is in mammary
gland Zn secretion.
In summary, results from this study document for the first time
that Zn transport in the mammary gland during lactation is
regulated in a biphasic manner. First, Zn is accumulated into a
peri-nuclear storage pool that includes mitochondria and the Golgi
apparatus. Following subsequent lactogenic stimulation, Zn is
redistributed into a vesicular pool for secretion from the mammary
gland into milk. Our observations in mammary epithelial cells are
consistent with that in prostate whereby autometallographic
imaging illustrates that Zn is confined to vesicles associated with
the apical (luminal) membrane [22,53]. Together these data
suggest that the large amount of Zn that is secreted into the two
most Zn-rich biological fluids (milk and prostate fluid) may utilize
similar processes which are clearly regulated through the
integration of numerous Zn transporters. Further studies are
needed to understand the complex integration and regulation of
this process in highly specialized secretory tissues.
Materials and Methods
Ethics Statement
This study was approved by Central Biological Laboratory at
the Pennsylvania State University, which is accredited by the
Figure 5. Labile Zn pools are associated with a distinct compartment directly proximal to the endoplasmic reticulum. Representative
confocal micrographs of mammary epithelial cells treated with FluoZin-3 (green) and ER Tracker (red) which illustrate that ‘‘labile’’ Zn pools do not
exist within the endoplasmic reticulum and are, in fact, associated with a distinct compartment proximal to the endoplasmic reticulum (merge).
doi:10.1371/journal.pone.0011078.g005
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Care (AAALAC). All animal studies have been conducted
according to Animal Welfare Act and the Public Health Service
Policy. The animals were housed in pathogen-free units at The
Pennsylvania State University, in compliance with IACUC
regulations (IACUC #28141). Animals were maintained in a
controlled environment which included filtered air and a 12 hour
light/dark cycle. All animals had free access to food and water.
Mice –Virgin or lactating mice (lactation day 4–5) were obtained
commercially (Charles River) and fed commercially available
rodent chow ad libitum. To modulate circulating prolactin
concentrations, mice (n=5 mice/group) mice were injected with
either bromocriptine (intraperitoneal, 0.4 mg/100 g body weight)
in 20 mM tartaric acid/30% ethanol; haloperidol (subcutaneous,
1mg/kg body weight) in 20 mM tartaric acid/30% ethanol; or
vehicle alone (20 mM tartaric acid/30%ethanol). Mice were killed
by CO2 asphyxiation and blood drawn by cardiac puncture.
Prolactin concentration was measured using a commercially
available ELISA kit (Amersham Pharmacia Biotech).
Tissue sections
Inguinal mammary glands were dissected from lactating mice
and plunge-frozen in an ice-cold isopentane bath. Tissue sections
(20 mm) were mounted intact on silicon nitride windows (Silson,
Blisworth, U.K.) and thawed onto windows at room temperature.
Sections were stored desiccated at room temperature until
transported to Argonne National Laboratory for X-ray fluorescent
microscopy.
X-Ray Fluorescence Microscopy
Sections were imaged with the scanning x-ray microprobe at
beamline 2-ID-E at the Advanced Photon Source (Argonne, IL).
Undulator-generated x-rays of 10-keV incident energy were
monochromatized with a single bounce Si S111T monochromator
and focused to a measured spot size of 0.460.5 mm using Fresnel
zone plate optics (X-radia, Concord, CA). Cells were raster-
scanned in steps of 1.0 mm, and fluorescence spectra were
collected for 1 s per pixel with a single-element silicon drift
detector (Vortex-EX, SII Nanotechnology, CA). Quantitation and
image-processing of the x-ray fluorescence (XRF) datasets was
performed with MAPS software (25). Quantitation of elemental
content was achieved by fitting XRF spectra at each pixel, and
comparing against a calibration curve derived from measurements
of thin-film standards NBS-1832 and NBS-1833 (National Bureau
of Standards, Gaithersburg, MD).
Cell culture
Mouse mammary epithelial cells (HC11) were a gift from Dr.
Jeffery Rosen (Houston, Texas) and used with permission of Dr. Bernd
Groner (Institute for Biomedical Research, Frankfurt, Germany).
Cells were routinely maintained in a non-secreting phenotype by
culturing in ‘‘growth medium’’ (RPMI 1640 supplemented with 10%
fetal bovine serum, insulin (5 mg/mL), EGF (10 ng/mL) and
gentamycin). Where indicated, cells were differentiated to a secreting
phenotype in ‘‘secretion medium’’ consisting of serum-free RPMI
1640, supplemented with insulin (5 mg/mL), prolactin (PRL, 1 mg/
mL) and cortisol (1 mM) for up to 48 h.
Figure 6. Labile Zn pools are partially associated with the Golgi apparatus. Representative confocal micrographs illustrate that FluoZin-3
(green) and Bodipy TR (red) are largely co-localized (merge, yellow) in non-secreting mammary epithelial cells (panel A). Mammary epithelial cells
were treated with prolactin and cortisol for 24 h differentiate to a secreting phenotype (panel B). Confocal micrographs of FluoZin-3 (green) and
Bodipy TR (red) in secreting mammary epithelial cells illustrate partial co-localization (merge, yellow) of ‘‘labile’’ Zn and the Golgi apparatus in
hormonally treated cells. Moreover, distinct non-Golgi apparatus-associated Zn pools were detected in secreting cells.
doi:10.1371/journal.pone.0011078.g006
Zn Pools in Mammary Gland
PLoS ONE | www.plosone.org 8 June 2010 | Volume 5 | Issue 6 | e11078Visualization and assessment of changes in zinc pools in
mitochondria (RhodZin-3) and vesicles (FluoZin-3)
To first validate that RhodZin-3 and FluoZin-3 specifically stain
mitochondria and vesicle Zn pools, respectively, cells were seeded
onto glass coverslips and cultured overnight until ,60% confluent.
Cells were rinsed twice with PBS then loaded with RhodZin-3 AM
or FluoZin-3 AM (1 mM in DMSO containing pluronic acid 127
to a final concentration of 0.02%; Invitrogen) following manufac-
turer’s instructions in OptiMEM for 1 h at 37uC. Cells were
briefly rinsed twice with PBS and washed with PBS for 30 min at
25uC with constant shaking. Images were collected from live cells
using a FV-1000 confocal microscope.
To quantify Zn accumulation in mitochondria and vesicles, cells
were cultured until ,80% confluence in 96-well optical bottom
black-sided plates and differentiated to a secreting phenotype for
48 h were noted. Cells were rinsed twice with PBS then loaded
with RhodZin-3 AM or FluoZin-3 AM as described above.
Fluorescence of RhodZin-3 AM (excitation 550 nm, emission.
575 nm) and FluoZin-3 (excitation 494 nm, emission 516 nm) was
measured at 25uC using FLUOstar OPTIMA plate reader (BMG
Labtech) spectrofluorimeter with FLUOstar OPTIMA software
version 1.32R2. Cellular protein concentration was determined by
the Bradford assay (Pierce) and fluorescence measurements were
normalized to total protein concentration. To determine if Zn is
redistributed from mitochondria and vesicles in response to
prolactin, cells were cultured until ,80% confluence in 96-well
optical bottom black-sided plates and differentiated to a secreting
phenotype for 48 h then subsequently treated with prolactin for up
to 16 h. Mitochondrial and vesicular Zn pools were quantified as
described above.
Next, to identify the vesicular compartments that accumulate
Zn, cells were cultured on glass coverslips to ,80% confluency
and pre-treated with chloroquine disphosphate salt (Sigma,
100uM for 180 min) to disrupt lysosomes. Control experiments
using Lysotracker Green (Molecular Probes, 1:1000 dilution for
30 mins at 37uC) first verified that chloroquine diphosphate
treatment disrupted the lysosomes by confocal imaging. Cells pre-
treated with chloriquinone were secondarily treated with FluoZin-
Figure 7. Labile Zn pools are disrupted by Brefledin A treatment. Representative confocal micrographs of p58 (Golgi apparatus marker)
visualized with Alexa FluorH 568-conjugated anti-mouse IgG in untreated (p58 2BFA) and Brefeldin A-treated (p58 +BFA) mammary epithelial cells.
Images verify that Brefeldin A treatment disrupts the Golgi apparatus in mammary epithelial cells. Representative confocal micrographs of FluoZin-3
in untreated cells (FluoZin-3 2BFA) and cells treated with Brefeldin A (FluoZin-3 +BFA). Images illustrate that the distribution of ‘‘labile’’ Zn pools is
diffuse by Brefeldin A treatment (inset) indicating that ‘‘labile’’ Zn is associated with the Golgi apparatus.
doi:10.1371/journal.pone.0011078.g007
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of ‘‘labile’’ Zn pools were collected. To determine if the Golgi
apparatus accumulated and/or redistributed Zn pools, cells were
first pre-treated with Brefeldin A (Sigma, BFA, 1 ug/ml for
120 min) to disrupt the Golgi apparatus. To verify that BFA
treatment disrupted the Golgi apparatus, subcellular localization
of the Golgi protein p58 was determined in cells pre-treated with
BFA and compared with untreated cells. To determine the sub-
cellular localization of the p58 protein, HC11 cells plated on to
glass coverslips, were fixed in phosphate buffered-paraformalde-
hyde (4%; w/v), pH 7.4, for 10 min, washed in PBS, and
permeabilized with Triton X-100 (0.5% in PBS) for 5 min. Non-
specific binding was blocked with 5% goat serum in PBS for
60 min followed by incubation with p58 antibody (Sigma, 1:100
dilution in 5% goat serum/1% BSA/0.5% Triton-X100) for
60 minutes. After extensive washing with PBS, p58 antibody was
detected with Alexa FluorH 568-conjugated anti-mouse IgG (1 mg/
ml; Invitrogen) for 20 min at room temperature shielded from
light. Cells were washed, mounted in ProLong Gold (Invitrogen),
and sealed with nail polish. Cells pre-treated with Brefeldin A were
secondarily treated with FluoZin-3 AM as described above to
visualize ‘‘labile’’ Zn pools and images of ‘‘labile’’ Zn pools were
collected. To verify that the Golgi apparatus accumulated Zn
pools, cells were cultured on glass coverslips to ,80% confluency,
rinsed twice with PBS then loaded with BODIPY TR dye-labeled
sphingolipid (5mg in sterile, deionized water to a final concentra-
tion of 0.5mM sphingolipid, Invitrogen) following manufacturer’s
instructions in OptiMEM for 30 minutes at 4uC. Cells were
subsequently treated with FluoZin-3 AM to visualize ‘‘labile’’ zinc
pools, and washed with PBS for 30 min at 25uC with constant
shaking. Images were collected from live cells as described above.
To determine if the endoplasmic reticulum accumulated Zn pools,
cells were cultured on glass coverslips to ,80% confluency. Cells
were rinsed twice with PBS then loaded with ER-Tracker Dye
(100 mg in DMSO to a final concentration of 90.9% w/v;
Invitrogen) following manufacturer’s instructions in OptiMEM for
60 minutes at 37uC. Cells were subsequently treated with FluoZin-
3 AM to visualize ‘‘labile’’ zinc pools, and washed with PBS for
30 min at 25uC with constant shaking. Images were collected from
live cells using as described above.
Statistical analysis
Results are presented as mean 6 standard deviation. A
minimum of at least two independent experiments were conducted
with sample sizes as indicated. Statistical comparisons were
performed using Student’s t-test (Prism Graph Pad, Berkeley,
CA) and a significant difference was demonstrated at p,0.05.
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